论文部分内容阅读
表皮生长因子 (epidermalgrowthfactor,EGF)对于创伤愈合 ,尤其是对难愈合创面修复的作用已经得到了动物试验和临床试验的证实。军事医学科学院生物工程研究所用于创伤修复的rhEGF冻干粉剂已于 2 0 0 0年 4月获得国家一类新药证书 (2 0 0 0S_1 1号 )。为了更好地满足临床用药的
The role of epidermal growth factor (EGF) in wound healing, especially in the healing of refractory wounds, has been confirmed both in animal experiments and in clinical trials. The rhEGF lyophilized powder for wound healing in the Academy of Biomedical Engineering of the Academy of Military Medical Sciences was awarded the first national certificate of new drug (2000s_1) in April 2000. In order to better meet the clinical medication